DarioHealth Corp. / Fundamentals
Income statement
- Net revenue
€23.29M - Cost of goods sold
€10.49M - Gross profit
€12.81M - SG&A expenses
€33.18M - R&D expenses
€15.92M - EBITDA
-€32.64M - D&A
€4.35M - EBIT
-€36.91M - Interest expenses
€45.47K - EBT
€32.40M - Tax expenses
€121.84K - Net income
-€13.14M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€8.98M - Changes in working capital
€20.27M - Operating cash flow
-€22.99M - Capex
€109.82K - Other investing cash flow
€0.00 - Net investing cash flow
-€109.82K - Total cash dividends paid
€0.00 - Issuance of common stock
€5.79M - Debt repayment
€158.73K - Other financing cash flow
-€1.61M - Net financing cash flow
€21.68M - Foreign exchange effects
€8.58K - Net change in cash
-€1.58M - Cash at end of period
€18.84M - Free cash flow
-€22.88M
Balance sheet
- Cash and cash equivalents
€19.02M - Cash and short-term investments
€19.02M - Total receivables
€2.19M - Inventory
€0.00 - Other current assets
€6.39M - Total current assets
€27.60M - Property, plant & equipment
€0.00 - Goodwill
€49.27M - Intangible assets
€14.48M - Long-term investments
€67.78K - Other non-current assets
€1.52M - Total non-current assets
€65.34M - Total assets
€92.94M - Accounts payable
€2.90M - Short-term debt
€437.58K - Other current liabilities
€4.41M - Total current liabilities
€8.37M - Long-term debt
€27.22M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€2.98M - Total non-current liabilities
€29.67M - Total liabilities
€38.04M - Common stock
€3.43K - Retained earnings
-€362.91M - Other equity
€0.00 - Total equity
€54.90M - Total liabilities and shareholders' equity
€92.94M
Company information
- Market capitalization
€531.26M - Employees
196 - Enterprise Value
€62.34M
Company ratios
- Gross margin
-
55.0% Even with peer group: 50.6% - EBITDA margin
-
-140.1% Much better than peer group: -1,541.2% - EBIT margin
-
-158.5% Much better than peer group: -1,652.8% - EBT margin
-
139.1% Much better than peer group: -1,631.1% - Net margin
-
-56.4% Much better than peer group: -1,628.8% - ROE
-
-23.9% Much worse than peer group: 2.0% - ROA
-
-14.1% Even with peer group: -10.4% - Asset turnover
-
25.1% Much worse than peer group: 87.1% - FCF margin
-
-99.2% Much better than peer group: -1,334.0% - FCF yield
-4.3% - Efficiency ratio
240.1% - Net sales per employee
-
€118.84K - Net income per employee
-
-€67.04K